These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12041844)

  • 1. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 2. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmaceutical industry and clinical drug research].
    Huttunen MO
    Duodecim; 2000; 116(24):2813-5. PubMed ID: 12077886
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
    ten Cate JW; Büller HR
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Institutional review boards (IRBs) would have an increased role in international research.
    Maloney DM
    Hum Res Rep; 2002 Oct; 17(10):9. PubMed ID: 12731498
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials in India sponsored by the pharmaceutical industry: a proposal for reforms.
    Pai M; Colford JM
    Natl Med J India; 2002; 15(2):93-6. PubMed ID: 12044124
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dishonesty in clinical trials is expensive for the society 1].
    Heslet L; Nielsen JD; Schierbeck J
    Ugeskr Laeger; 2003 Jun; 165(26):2671-2. PubMed ID: 12886555
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dishonesty in clinical trials is expensive for the society 2].
    Lund BA; Nordby G
    Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dishonesty in clinical trials is expensive for the society 3].
    Waldorff S
    Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

  • 16. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dishonesty in clinical trials is expensive for the society].
    Gøtzsche PC
    Ugeskr Laeger; 2003 Apr; 165(16):1691-2. PubMed ID: 12756834
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to data from clinical trials sponsored by pharmaceutical companies.
    West R
    Addiction; 2007 May; 102(5):682-3. PubMed ID: 17493100
    [No Abstract]   [Full Text] [Related]  

  • 20. Data availability for industry sponsored trials: what should medical journals require?
    Steinbrook R; Kassirer JP
    BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.